Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a


Journal

JCO precision oncology
ISSN: 2473-4284
Titre abrégé: JCO Precis Oncol
Pays: United States
ID NLM: 101705370

Informations de publication

Date de publication:
06 2023
Historique:
medline: 28 6 2023
pubmed: 26 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

In this case report, we discuss a case of pancreatic cancer bearing a BRAF fusion, leading to MAPK activation, MLHph, and finally MSI.

Identifiants

pubmed: 37364232
doi: 10.1200/PO.22.00650
pmc: PMC10309529
doi:

Substances chimiques

Proto-Oncogene Proteins B-raf EC 2.7.11.1
BRAF protein, human EC 2.7.11.1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2200650

Commentaires et corrections

Type : ErratumIn

Références

Int J Mol Sci. 2019 Oct 25;20(21):
pubmed: 31731495
Clin Cancer Res. 2014 Jun 15;20(12):3087-93
pubmed: 24727320
Acta Neuropathol. 2011 Jun;121(6):763-74
pubmed: 21424530
JCO Precis Oncol. 2017;2017:
pubmed: 29850653
Nature. 2016 Mar 3;531(7592):47-52
pubmed: 26909576
J Exp Clin Cancer Res. 2020 Oct 28;39(1):227
pubmed: 33115526
Cancer Res. 2019 Mar 15;79(6):1047-1053
pubmed: 30643016
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
Clin Cancer Res. 2019 Jan 1;25(1):378-389
pubmed: 30279230
Mol Cell. 2014 Sep 18;55(6):904-915
pubmed: 25219500
Int J Mol Sci. 2018 Nov 07;19(11):
pubmed: 30405053
J Clin Oncol. 2020 Jan 1;38(1):1-10
pubmed: 31682550
Cancer Res. 2003 Sep 1;63(17):5209-12
pubmed: 14500346
Int J Cancer. 2016 Feb 15;138(4):881-90
pubmed: 26314551
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
Cancer Discov. 2016 Feb;6(2):166-75
pubmed: 26658419
Cancer Discov. 2018 Sep;8(9):1087-1095
pubmed: 29802158
Gastroenterology. 2019 Jun;156(8):2242-2253.e4
pubmed: 30836094
Nature. 1993 Jun 10;363(6429):558-61
pubmed: 8505985
NPJ Precis Oncol. 2021 Jul 20;5(1):69
pubmed: 34285332
Genes (Basel). 2020 Dec 29;12(1):
pubmed: 33383713
Am J Surg Pathol. 2016 Oct;40(10):1390-9
pubmed: 27438990
Cancer Res. 2001 Apr 1;61(7):3139-44
pubmed: 11306499

Auteurs

Kathrin Heinrich (K)

Department of Medicine III and Comprehensive Cancer Centre (CCC), LMU University Hospital Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

Laura E Fischer (LE)

Department of Medicine III and Comprehensive Cancer Centre (CCC), LMU University Hospital Munich, Munich, Germany.

Enrico N De Toni (EN)

Department of Medicine II and Comprehensive Cancer Centre (CCC), LMU University Hospital Munich, Munich, Germany.

Daniel Markwardt (D)

Department of Medicine II and Comprehensive Cancer Centre (CCC), LMU University Hospital Munich, Munich, Germany.

Daniel Roessler (D)

Department of Medicine II and Comprehensive Cancer Centre (CCC), LMU University Hospital Munich, Munich, Germany.

Georg Beyer (G)

Department of Medicine II and Comprehensive Cancer Centre (CCC), LMU University Hospital Munich, Munich, Germany.

Michael Günther (M)

Institute of Pathology, Ludwig Maximilians University (LMU), Munich, Germany.

Steffen Ormanns (S)

Institute of Pathology, Ludwig Maximilians University (LMU), Munich, Germany.

Frederick Klauschen (F)

German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
Institute of Pathology, Ludwig Maximilians University (LMU), Munich, Germany.

Wolfgang G Kunz (WG)

Department of Radiology and Comprehensive Cancer Center (CCC Munich LMU), University Hospital, LMU Munich, Munich, Germany.

Stefan Fröhling (S)

Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKTZ), Heidelberg, Germany.
DKTK, Heidelberg, Germany.

Tilman Brummer (T)

Institute of Molecular Medicine, ZBMZ, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Comprehensive Cancer Center Freiburg (CCCF), Medical Center, University of Freiburg, Freiburg, Germany.
German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Volker Heinemann (V)

Department of Medicine III and Comprehensive Cancer Centre (CCC), LMU University Hospital Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

C Benedikt Westphalen (CB)

Department of Medicine III and Comprehensive Cancer Centre (CCC), LMU University Hospital Munich, Munich, Germany.
German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH